profit from every $100 of sales.
$0$100
Jin Medical International
$3.50-9.56% today
-32.8% in 1 year
1-year low $1.811-year high $5.58
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $467.71 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Jin Medical International sold, what it kept, and what it did with the cash.
Sales went from $19.2 million in 2022 to $20.7 million in 2025, with $1.19 million of profit last year.
SalesProfit
Jin Medical International vs. similar companies
Jin Medical International grows the slowest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Jin Medical International | 467.7× · Very expensive | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads Jin Medical International's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 19 | 20 | 24 | 21 | |
| 6 | 7 | 10 | 6 | |
| 2 | 3 | 4 | 1 | |
| 2 | 3 | 4 | 1 | |
| 3 | 3 | 4 | 1 | |
| 0.36 | 0.40 | 0.40 | – | |
| 32.3% | 34.2% | 40.4% | 29.2% | |
| 11.1% | 14.5% | 15.5% | 2.9% | |
| 14.1% | 14.5% | 15.6% | 5.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 21 | 33 | 46 | 53 |
| Cash | 5 | 7 | 8 | 7 |
| Total debt | – | 4 | 12 | 19 |
| Total liabilities | 6 | 9 | 17 | 24 |
| 15 | 24 | 29 | 30 | |
| 8 | 7 | 8 | – | |
| 11.0% | 8.1% | 7.1% | 1.0% | |
| 17.8% | 12.0% | 12.8% | 4.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2 | 3 | -1 | 3 | |
| 0 | 0 | 1 | 7 | |
| 2 | 3 | -2 | -4 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 467.7×
- –
- –
- 5.9×
- 26.9×
- –
- 593.0×
- -0.7%
- 0.2%
- 0.0%
Profitability
- 29.2%
- 2.9%
- 5.8%
- 4.2%
- 1.0%
- 7.0%
- 4.1%
- 2.2%
- 2.1%
- 7.5%
Growth
- +2.5%
- –
- −59.8%
- –
- +1.4%
Financial health
- 11.9×
- 0.64
- 35.4%
- –
- 1.86
- 1.65
- 0.39
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 35%of 952
Bottom 32%of 884
Bottom 1%of 601
Bottom 23%of 886
Bottom 34%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Jan 23, 2026 | 0.16 | – | – |
News
Why SBC Medical Stock Skyrocketed on FridayYahoo Finance · Nov 14, 2026SBC Medical Group Holdings GAAP EPS of $0.15 beats by $0.03, revenue of $59M beats by $10.11MSeeking Alpha · Nov 13, 2026Seastar Medical anticipates NEUTRALIZE-AKI enrollment completion by midyear 2027 while preparing modular PMA submissionsSeeking Alpha · Nov 11, 2026Orthofix Medical Inc. Q3 2026 Earnings Call SummaryYahoo Finance · Nov 9, 2026Icu Medical signals 2026 results toward high end of $415M-$435M EBITDA and $8.60-$9 EPS range as logistics consolidation normalizesSeeking Alpha · Nov 5, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
17No pass
Benjamin Graham
47No pass
Philip Fisher
21No pass
Peter Lynch
39No pass
Joel Greenblatt
0No pass
Charlie Munger
19No pass
Terry Smith
13No pass
Questions about Jin Medical International
Is Jin Medical International a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Jin Medical International AI analysis
What does Jin Medical International do?
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. It is in Medical Instruments & Supplies.
Does Jin Medical International pay a dividend?
No. Jin Medical International does not pay a dividend at the moment.
Is Jin Medical International stock halal?
Yes. Jin Medical International passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Jin Medical International stock done over the past year?
Down 32.8% over the past twelve months, to $3.50. It traded between $1.81 and $5.58 and is 37.3% below its high.
Who are Jin Medical International's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Jin Medical International's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.